Dato’ Dr. Meheshinder Singh Colorectal Surgery


Consultant - Colorectal Surgeon , Experience:

Book Appointment

About Doctor

Dato’ Dr. Meheshinder Singh is among the top colorectal surgeon in Kuala Lumpur, Malaysia.

Dato’ Dr Meheshinder is a member of numerous learned societies and professional organisations. He is among the founding members and is the current President of the Malaysian Society of Colorectal Surgeons.

He is the council member of the Asia Pacific Federation of Coloproctology (APFCP) and is the Organising Chairperson for the APFCP Congress to be held in KL in 2019. He is also the founder and past President of the Colorectal Cancer Survivorship Society Malaysia.

Dato’ Dr Meheshinder enjoys teaching and has been involved in several GI workshops. He has published articles in several local and peer reviewed journals and in two international book chapters. He is amongst the reviewers and contributed to the development of Clinical Practice Guidelines for Colorectal Cancer.

Hospital

Pantai Hospital, Kuala Lumpur, Malaysia

Specialization

  • Surgical management of GI cancers particularly colorectal cancers and in the management of perianal pathologies
  • Minimal invasive surgical procedures

Procedures Performed

  • Surgery and Colon & Rectal Surgery,
  • Gastro-Intestinal (GI) Cancer Cancers,
  • Perianal Pathologies e.g. Haemorrhoids,
  • Anal Fissures,
  • Perianal Abscesses,
  • Fistulae,
  • Pilonidal Sinus,
  • Upper & Lower GI Endoscopies,
  • Minimal Invasive Procedures
  • General Surgical Operations

Research & Publications

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy